Risk prediction in early triple negative breast cancer

被引：0
|
作者：
Mason, Sofia [1 ,2 ]
机构：
[1] Chris OBrien Lifehouse, Sydney, NSW, Australia
[2] UNSW Sydney, Garvan Inst Med Res, St Vincents Healthcare Clin Campus, Sydney, NSW, Australia
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 387卷
关键词：
SIGNATURE;
D O I：
10.1136/bmj.q2088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [42] Optimal Systemic Treatment for Early Triple-Negative Breast Cancer
    Furlanetto, Jenny
    Loibl, Sibylle
    BREAST CARE, 2020, 15 (03) : 217 - 226
  • [43] Review of Capecitabine for the Treatment of Triple-Negative Early Breast Cancer
    Steger, G. G.
    Barrios, C.
    O'Shaughnessy, J.
    Martin, M.
    Gnant, M.
    CANCER RESEARCH, 2010, 70
  • [44] A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer
    Pan, Wen-kai
    Ren, Si-yan
    Zhu, Liao-xiang
    Lin, Bao-chai
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (02): : 71 - 80
  • [45] Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin
    Kubeczko, Marcin
    Michalik, Anna
    Badora-Rybicka, Agnieszka
    Polakiewicz-Gilowska, Anna
    d'Amico, Andrea
    Kalemba, Michal
    Lesniak, Aleksandra
    Swiderska, Katarzyna
    Mianowska-Malec, Marta
    Pasierbek, Agnieszka
    Lanoszka, Barbara
    Chomik, Konstanty
    Bobek-Billewicz, Barbara
    Jarzab, Michal
    CANCER RESEARCH, 2022, 82 (04)
  • [46] Evaluation of contrast-enhanced ultrasonography for early prediction of response to neoadjuvant chemotherapy in triple negative breast cancer
    Masumoto, N.
    Kadoya, T.
    Murakami, C.
    Gouda, N.
    Sasada, S.
    Emi, A.
    Haruta, R.
    Kataoka, T.
    Okada, M.
    CANCER RESEARCH, 2017, 77
  • [47] Breast cancer stem cells in triple negative vs. non triple negative breast cancer
    Comanescu, M. V.
    Dobre, M.
    Ardeleanu, C.
    Butur, G.
    Bussolati, G.
    HISTOPATHOLOGY, 2012, 61 : 17 - 17
  • [48] Combined Genetic and Nutritional Risk Models of Triple Negative Breast Cancer
    Lee, Eunkyung
    Levine, Edward A.
    Franco, Vivian I.
    Allen, Glenn O.
    Gong, Feng
    Zhang, Yanbin
    Hu, Jennifer J.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (06): : 955 - 963
  • [49] Triple-Negative Breast Cancer: Risk Factors to Potential Targets
    Schneider, Bryan P.
    Winer, Eric P.
    Foulkes, William D.
    Garber, Judy
    Perou, Charles M.
    Richardson, Andrea
    Sledge, George W.
    Carey, Lisa A.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8010 - 8018
  • [50] A radiogenomic approach for triple-negative breast cancer risk stratification
    Noor, Humaira
    Zheng, Yuanning
    Mantz, Adam
    Zhou, Ryle
    Kozlov, Andrew
    DeMartini, Wendy B.
    Chen, Shu-Tian
    Okamoto, Satoko
    Ikeda, Debra
    Mattonen, Sarah
    Napel, Sandy
    Telli, Melinda L.
    Sledge, George
    Kurian, Allison
    Satoyoshi, Mina
    Gevaert, Olivier
    Itakura, Haruka
    CANCER RESEARCH, 2024, 84 (06)
12345